Understanding Total Patient Picture Central to Designing Targeted Treatments
Patients with rheumatoid arthritis (RA) who took biologics or triple therapy had a longer fail time than patients who took methotrexate oral monotherapy, suggesting that these treatments may be a good follow-up to failed first-line methotrexate treatment.
Physician and pharmacist collaboration is key within the complex pain management prescribing landscape.
Golimumab is the only fully-human anti-tumor necrosis factor (TNF) alpha therapy that is administered with a 30-minute infusion.
This year, the FDA is on pace to approve about 38 new medications. Here is a look at 6 of these.
This year, the FDA is on pace to approve about 38 new medications. Here is a look at 6 of these.
Breakthrough pain estimates vary, but as many as 50% of patients diagnosed with cancer and chronic pain have pain levels that are not adequately controlled
Here is how to distinguish between those who need prescriptions to manage pain and those seeking controlled substances for illicit reasons.
The tablets did not get approval for managing fibromyalgia, however, according to a press release from Pfizer.
It is currently the first and only extended-release, intra-articular injection available for OA.
Eliminating barriers to non-drug and non-opioid pain management would reduce the effects of the opioid epidemic.
Postoperative pain management presents a major challenge to patients and health care providers.
Pharmacists are in a prime position to help patients manage acute and chronic pain.
In this video from PainWeek 2017, Hal Blatman, MD, medical director of Blatman Health and Wellness Center, discusses the most common misconceptions that patients have about pain.
In this video from PainWeek 2017, Hal Blatman, MD, medical director of Blatman Health and Wellness Center, discusses whether the FDA should reduce the availability of high-dose opioids in response to the growing opioid abuse epidemic.
In this video from PainWeek 2017, Hal Blatman, MD, medical director of Blatman Health and Wellness Center, discusses the relationship between chronic pain and stress.
In this video from PainWeek 2017, Jeremy Adler, MS, PA-C, co-owner of Pacific Pain Medicine, discusses why opioid abuse has become an increasingly urgent issue.
In this video from PainWeek 2017, Jeremy Adler, MS, PA-C, co-owner of Pacific Pain Medicine, discusses the pharmacist's role in combating the opioid abuse epidemic.
In this video from PainWeek 2017, Jeremy Adler, MS, PA-C, co-owner of Pacific Pain Medicine, discusses the challenges facing abuse-deterrent opioids as their manufacturers attempt to bring them to market.
In this video from PainWeek 2017, Jeremy Adler, MS, PA-C, co-owner of Pacific Pain Medicine, discusses the mechanisms by which abuse-deterrent opioids prevent misuse.
In this video from PainWeek 2017, Jeremy Adler, MS, PA-C, co-owner of Pacific Pain Medicine, discusses the benefits of abuse-deterrent opioids.
In this video from PainWeek 2017, Hal Blatman, MD, medical director of Blatman Health and Wellness Center, discusses treatment options for sleep-related pain.
Millennials half as likely as baby boomers to take opioids to treat pain.
More than 20 million Americans are afflicted with knee osteoarthritis and there is no cure.
